异喹啉-7-甲酰胺 | 1158755-26-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 异喹啉-7-甲酰胺
• 英文名称: Isoquinoline-7-carboxamide
• CAS: 1158755-26-0
• 化学式: C₁₀H₈N₂O
• 分子量: 172.18
• InChiKey: RGGLAPZYXTXDGZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  56
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] NOVEL ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES<br/>[FR] NOUVEAUX DÉRIVÉS D'ISOQUINOLINE ET COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES POUR LE TRAITEMENT DE MALADIES
  申请人：GALAPAGOS NV

  公开号：WO2022128850A1

  公开（公告）日：2022-06-23

  The present invention discloses compounds according to Formula (I): Wherein R1, R2, R3a, R3b, R4, Het, L1, L2, L3, and the subscript n are as defined herein. The present invention relates to compounds inhibiting discoidin domain receptors (DDRs), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of fibrotic diseases, inflammatory diseases, respiratory diseases, autoimmune diseases, metabolic diseases, cardiovascular diseases, and/or proliferative diseases by administering a compound of the invention.

  本发明披露了符合式（I）的化合物：其中，R1、R2、R3a、R3b、R4、Het、L1、L2、L3和下标n的定义如本文所述。本发明涉及抑制盘状蛋白结构域受体（DDRs）的化合物，其制备方法，包含其的制药组合物，以及使用该化合物的治疗方法，用于预防和/或治疗纤维化疾病、炎症性疾病、呼吸系统疾病、自身免疫性疾病、代谢性疾病、心血管疾病和/或增生性疾病，通过给予本发明的化合物。
• Compounds and compositions for the inhibition of NAMPT
  申请人：Forma TM, LLC

  公开号：US10456382B2

  公开（公告）日：2019-10-29

  The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below:

  本发明涉及抑制 NAMPT 的化合物和组合物、其合成、应用和解毒剂。本发明的一种说明性化合物如下所示：
• N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES
  申请人：Elan Pharmaceuticals, Inc.

  公开号：EP1453789A2

  公开（公告）日：2004-09-08
• BICYCLIC COMPOUNDS
  申请人：Vivace Therapeutics, Inc.

  公开号：US20220298102A1

  公开（公告）日：2022-09-22

  Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating deseases, such as cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
• [EN] N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES<br/>[FR] DERIVES 1,3-DIAMINO-2-HYDROXYPROPANE N-N'-SUBSTITUES
  申请人：ELAN PHARM INC

  公开号：WO2003040096A2

  公开（公告）日：2003-05-15

  Disclosed are compounds of the formula (I), wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of betasecretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.